Crédit Industriel et Commercial’s Verona Pharma VRNA Stock Holding History

Crédit Industriel et Commercial’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-137,552	Closed	-$14.7M	–	426
2025 Q3	$14.7M	Buy	+137,552	New	+$14.4M	1.23%	14

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Crédit Industriel et Commercial's VRNA Position: Q4 2025 in Review

Crédit Industriel et Commercial sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 137,552 shares — an estimated $14.7M sold.

Crédit Industriel et Commercial first reported a position in VRNA in Q3 2025 and held it in 1 quarter. The position peaked at $14.7M in Q3 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Crédit Industriel et Commercial reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Crédit Industriel et Commercial sold 137,552 Verona Pharma shares in Q4 2025, an estimated $14.7M.
Crédit Industriel et Commercial first reported a position in Verona Pharma in Q3 2025 and held it in 1 quarter.
Crédit Industriel et Commercial's Verona Pharma position peaked at $14.7M in Q3 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Crédit Industriel et Commercial's 13F filing for Q4 2025, filed 3 Feb 2026.